These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10924275)

  • 1. CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid-beta protein precursor and cathepsin D in human cells.
    Golabek AA; Kida E; Walus M; Kaczmarski W; Michalewski M; Wisniewski KE
    Mol Genet Metab; 2000 Jul; 70(3):203-13. PubMed ID: 10924275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular trafficking of the JNCL protein CLN3.
    Haskell RE; Derksen TA; Davidson BL
    Mol Genet Metab; 1999 Apr; 66(4):253-60. PubMed ID: 10191111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of intracellular distribution and trafficking of the CLN3 protein in fusion with the green fluorescent protein in vitro.
    Kida E; Kaczmarski W; Golabek AA; Kaczmarski A; Michalewski M; Wisniewski KE
    Mol Genet Metab; 1999 Apr; 66(4):265-71. PubMed ID: 10191113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective lysosomal arginine transport in juvenile Batten disease.
    Ramirez-Montealegre D; Pearce DA
    Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.
    Chan CH; Ramirez-Montealegre D; Pearce DA
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the Lysosomal Membrane Protein, CLN3, in the Regulation of Cathepsin D Activity.
    Cárcel-Trullols J; Kovács AD; Pearce DA
    J Cell Biochem; 2017 Nov; 118(11):3883-3890. PubMed ID: 28390177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for phosphorylation of CLN3 protein associated with Batten disease.
    Michalewski MP; Kaczmarski W; Golabek AA; Kida E; Kaczmarski A; Wisniewski KE
    Biochem Biophys Res Commun; 1998 Dec; 253(2):458-62. PubMed ID: 9878558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue.
    Pohl S; Mitchison HM; Kohlschütter A; van Diggelen O; Braulke T; Storch S
    J Neurochem; 2007 Dec; 103(6):2177-88. PubMed ID: 17868323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLN3 disease process: missense point mutations and protein depletion in vitro.
    Golabek AA; Kida E; Walus M; Kaczmarski W; Wujek P; Wisniewski KE
    Eur J Paediatr Neurol; 2001; 5 Suppl A():81-8. PubMed ID: 11589014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
    Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
    Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel interactions of CLN3 protein link Batten disease to dysregulation of fodrin-Na+, K+ ATPase complex.
    Uusi-Rauva K; Luiro K; Tanhuanpää K; Kopra O; Martín-Vasallo P; Kyttälä A; Jalanko A
    Exp Cell Res; 2008 Sep; 314(15):2895-905. PubMed ID: 18621045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype.
    Kwon JM; Rothberg PG; Leman AR; Weimer JM; Mink JW; Pearce DA
    Neurosci Lett; 2005 Oct; 387(2):111-4. PubMed ID: 16087292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression studies of CLN3 protein (battenin) in fusion with the green fluorescent protein in mammalian cells in vitro.
    Golabek AA; Kaczmarski W; Kida E; Kaczmarski A; Michalewski MP; Wisniewski KE
    Mol Genet Metab; 1999 Apr; 66(4):277-82. PubMed ID: 10191115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization and processing of CLN3, the protein associated to Batten disease: where is it and what does it do?
    Pearce DA
    J Neurosci Res; 2000 Jan; 59(1):19-23. PubMed ID: 10658181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. btn1, the Schizosaccharomyces pombe homologue of the human Batten disease gene CLN3, regulates vacuole homeostasis.
    Gachet Y; Codlin S; Hyams JS; Mole SE
    J Cell Sci; 2005 Dec; 118(Pt 23):5525-36. PubMed ID: 16291725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLN3p impacts galactosylceramide transport, raft morphology, and lipid content.
    Rusyn E; Mousallem T; Persaud-Sawin DA; Miller S; Boustany RM
    Pediatr Res; 2008 Jun; 63(6):625-31. PubMed ID: 18317235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CLN3 gene is a novel molecular target for cancer drug discovery.
    Rylova SN; Amalfitano A; Persaud-Sawin DA; Guo WX; Chang J; Jansen PJ; Proia AD; Boustany RM
    Cancer Res; 2002 Feb; 62(3):801-8. PubMed ID: 11830536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of BTN1, the yeast orthologue of the gene mutated in Batten disease.
    Pearce DA; Ferea T; Nosel SA; Das B; Sherman F
    Nat Genet; 1999 May; 22(1):55-8. PubMed ID: 10319861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X).
    Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M
    Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue expression and subcellular localization of CLN3, the Batten disease protein.
    Margraf LR; Boriack RL; Routheut AA; Cuppen I; Alhilali L; Bennett CJ; Bennett MJ
    Mol Genet Metab; 1999 Apr; 66(4):283-9. PubMed ID: 10191116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.